{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:43:24Z","timestamp":1771955004276,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12350-018-1309-5","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T11:11:50Z","timestamp":1528974710000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake"],"prefix":"10.1016","volume":"27","author":[{"given":"Renata Christian Martins","family":"Felix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9cio Maria","family":"Gouvea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane Cigagna Wiefels","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline Sampaio","family":"dos Santos Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia Beatriz Chaves Espinoso","family":"Schtruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Siciliano","family":"Colafranceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio Tinoco","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-1309-5_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00259-004-1670-2","article-title":"Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut","volume":"32","author":"de Groot","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1309-5_bib3","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1097\/RLU.0000000000001063","article-title":"Impact of Patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: A systematic review and meta-analysis","volume":"41","author":"Tang","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2008.05.020","article-title":"The changing face of heart transplantation","volume":"52","author":"Hunt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib6","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/TP.0000000000000618","article-title":"Use of [18F]FDG positron emission tomography to monitor the development of cardiac allograft rejection","volume":"99","author":"Daly","year":"2015","journal-title":"Transplantation"},{"key":"10.1007\/s12350-018-1309-5_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0735-1097(97)00180-0","article-title":"Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography","volume":"30","author":"Rechavia","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12350-012-9653-3","article-title":"Clinical value of a high-fat and lowcarbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"20","author":"Soussan","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12350-011-9358-z","article-title":"Value of FDG-PET\/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings","volume":"18","author":"Minamimoto","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2967\/jnmt.110.076489","article-title":"Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet","volume":"39","author":"Balink","year":"2011","journal-title":"J Nucl Med Technol"},{"key":"10.1007\/s12350-018-1309-5_bib12","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1007\/s12350-018-1309-5_bib13","doi-asserted-by":"crossref","first-page":"W151","DOI":"10.2214\/AJR.07.2409","article-title":"AJR suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet","volume":"190","author":"Williams","year":"2008","journal-title":"Am J Roentgenol"},{"key":"10.1007\/s12350-018-1309-5_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcmg.2010.01.004","article-title":"Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina","volume":"3","author":"Rogers","year":"2010","journal-title":"J Am Coll Cardiol Imag"},{"key":"10.1007\/s12350-018-1309-5_bib15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2967\/jnumed.114.138594","article-title":"A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: Implications for vulnerable coronary plaque imaging","volume":"55","author":"Demeure","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2013.05.004","article-title":"Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet","volume":"62","author":"Kobayashi","year":"2013","journal-title":"J Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11604-015-0428-z","article-title":"Comparison of myocardial F-18 FDG uptake between overnight and non-overnight fasting in non-diabetic healthy subjects","volume":"33","author":"Lee","year":"2015","journal-title":"Jpn J Radiol"},{"key":"10.1007\/s12350-018-1309-5_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.108.055616","article-title":"Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET\/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation","volume":"50","author":"Wykrzykowska","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib21","first-page":"219","article-title":"Measurement of standard uptake value in dual-head coincidence system","volume":"17","author":"Cheng","year":"2007","journal-title":"Bio-Med Mater Eng"},{"key":"10.1007\/s12350-018-1309-5_bib22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I- metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1309-5_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2967\/jnumed.115.154815","article-title":"Semiquantitative 123I-metaiodobenzylguanidine scintigraphy to distinguish pheochromocytoma and paraganglioma from physiologic adrenal uptake and its correlation with genotype-dependent expression of catecholamine transporters","volume":"56","author":"Van Berkel","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1309-5_bib24","first-page":"S359","article-title":"Usability of the heparin appositional whole body FDG PET\u2014new methods to reduce cardiac physiological accumulation","volume":"38","author":"Fujita","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1\u20132","key":"10.1007\/s12350-018-1309-5_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2008.03.026","article-title":"Cyclosporine A and rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma","volume":"358","author":"Tory","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1007\/s12350-018-1309-5_bib26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s12350-013-9798-8","article-title":"Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis","volume":"20","author":"Gormsen","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1309-5_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ehjci\/jev139","article-title":"European Association of Cardiovascular Imaging\/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation","volume":"9","author":"Badano","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-1309-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123017488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123017488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:05:36Z","timestamp":1761026736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123017488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1071358123017488"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-1309-5","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-1309-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}